SCHEMBL19086169

SCHEMBL19086169

CC[C@@H](NC(=O)c1ccc2[nH]ncc2c1)C(=O)N1CCc2sc(C(=O)Nc3cc(C)n(C)c3)cc2C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METTL3 Q86U44 1/20 0.37
ROCK2 O75116 2/20 0.36
HDAC6 Q9UBN7 1/20 0.36
LRRK2 Q5S007 3/20 0.35
MAOB P27338 4/20 0.35
DDR2 Q16832 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ABL1 P00519 2/20 0.35
SMO Q99835 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
BTK Q06187 1/20 0.34
BCR P11274 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19086167 0.90 METTL3 (0.37) METTL3ROCK2HDAC6LRRK2MAOB
SCHEMBL19085981 0.89 TRPV1 (0.41) ROCK2MAOBNPC1RAB9AKMT2A
SCHEMBL19085999 0.89 TRPV1 (0.41) ROCK2MAOBNPC1RAB9AKMT2A
SCHEMBL19086255 0.88 MEN1 (0.39) ROCK2LRRK2MAOBMEN1NPC1
SCHEMBL19085977 0.88 NPC1 (0.45) ROCK2HDAC6MAOBMEN1NPC1
SCHEMBL19086170 0.87 METTL3 (0.36) METTL3ROCK2HDAC6ABL1BTK
SCHEMBL19085978 0.86 ROCK2 (0.46) ROCK2MAOBNPC1RAB9ATRPV1
SCHEMBL19085989 0.86 MAOB (0.41) ROCK2MAOBNPC1RAB9AMAOA
SCHEMBL19086178 0.85 NPC1 (0.38) ROCK2MAOBMEN1NPC1RAB9A
SCHEMBL19086160 0.85 HDAC6 (0.38) METTL3ROCK2HDAC6ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017114275-A1 COMPOUND FOR INHIBITING ROCK, PREPARATION METHOD AND USE OF SAME 成都先导药物开发有限公司 2017-07-06 WO disclosed